Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis
Antibiotics (ABs) are common medications used for treating infections. In cancer patients treated with immune checkpoint inhibitors (ICIs), concomitant exposure to ABs may impair the efficacy of ICIs and lead to a poorer outcome compared to AB non-users. We report here the results of a meta-analysis...
Main Authors: | Fausto Petrelli, Alessandro Iaculli, Diego Signorelli, Antonio Ghidini, Lorenzo Dottorini, Gianluca Perego, Michele Ghidini, Alberto Zaniboni, Stefania Gori, Alessandro Inno |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/5/1458 |
Similar Items
-
Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies
by: Fausto Petrelli, et al.
Published: (2019-08-01) -
Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies [version 4; peer review: 2 approved]
by: Alice Indini, et al.
Published: (2022-05-01) -
Timing of Adjuvant Chemotherapy and Survival in Colorectal, Gastric, and Pancreatic Cancer. A Systematic Review and Meta-Analysis
by: Fausto Petrelli, et al.
Published: (2019-04-01) -
A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 Pandemic
by: Alberto Zaniboni, et al.
Published: (2020-08-01) -
Antibody-drug conjugates in treating older patients suffering from cancer: what is the real value?
by: Gianluca Perego, et al.
Published: (2021-12-01)